Skip to content

Quisanus has developed LegFit, a new intermittent pneumatic compression device (IPC device) with unique features for a treatment from hospital to home.

Features of the device

  • Small size, lightweight, neat, and easy to operate with one button

  • Powered by a reachargeable battery

  • Mobile app to change pressure and interval of the inflation cycle

  • Easily detachable cuff for cleaning purposes or changing of cuff size

  • Ready to be used in every day life situations everywhere, at work, at home, or during travel

Intended purpose

Deep Vein Thrombosis (DVT). Contributed by Creative Commons (CC BY-ND 2.0) Copyright © 2022, StatPearls Publishing LLC.

LegFit is an intermittent pneumatic compression device used for the treatment of various venous disorders and for the prevention of deep vein thrombosis (DVT), especially after surgery and long hospital stay. The basic mode of action is the reversal of venous stasis and to prevent blood clotting. It helps to relieve all conditions of chronic venous diseases (edemas, heavy and swollen legs, varicose veins, leg ulcers). It can also prevent venous disorders during pregnancy and long-distance travel.

The medical advantages of IPC are well documented in several hundred studies and strongly recommended in international guidelines, for example the S1 Guideline on Intermittent Pneumatic Compression of the German Society for Phlebology (AWMF037/007) or the Antithrombotic therapy and Prevention of Thrombosis, 9th edition, of the American College of Chest Physicians Evidence-Based Clinical Practice guidelines.

Efficacy of IPC

One of the remaining problems after a successful IPC treatment during hospital stay is that the patient is discharged without having the possibility to continue the IPC therapy.

Considering the literature, about 25% of these patients will have to be re-hospitalized due to DVT or pulmonary embolism.

It is strongly recommended to follow the IPC treatment, especially in cases, where medical drug treatment (blood thinners) is not possible or even contraindicated.

It is also indicated for any conditions of immobility of the lower leg (Hemiplegia with sensory disorder and edema). IPC is useful to treat edemas of various cause. In peripheral artery disease IPC is an option regarding special conditions.

Intended users

The device can be used by anybody irrespective of age and gender. There is no special training or education required to use the device. A technical support service is not necessary.

Cost saving

The device covers the need for prevention of further severe complications and helps to stay healthy. It contributes as well to reduce the economic burden of the health care system.


If you have any questions please contact us. We are gladly available during office hours.


Swiss Medtech Day 2024

Markus Adam and Kaspar Steiner once again attended Swiss Medtech Day in Bern together. And once again it was not boring.Under the theme of “Mastering

Read More »

Swiss Medtech Day 2023

Markus Adam, ICU tech Managing Director, and Kaspar Steiner, ICU tech Biomedical Engineer, once again spent an extremely inspiring day at the Kursaal Bern. In

Read More »


  1. A clinical comparison of pneumatic compression devices: The basis for selection
    Mary C. ProctorMSLazar, J. GreenfieldMDThomas W. WakefieldMDPaul J. ZajkowskiBS
    From the Department of Surgery, University of Michigan
    Journal of Vascular Surgery, Volume 35, Issue 4, April 2002, Pages 678
  2. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Clive Kearon, MD, PhD; Elie A. Akl, MD, MPH, PhD; Anthony J. Comerota, MD; Paolo Prandoni, MD, PhD; Henri Bounameaux, MD; Samuel Z. Goldhaber, MD, FCCP; Michael E. Nelson, MD, FCCP; Philip S. Wells, MD; Michael K. Gould, MD FCCP; Francesco Dentali, MD; Mark Crowther, MD; and Susan R. Kahn, MD
    in CHEST 2012; 141(2)(suppl): 7s-47S
  3. Dynamic Interface Pressure Monitoring System for the Morphological Pressure Mapping of Intermittent Pneumatic Compression Therapy
    by Shumi Zhao 1,Rong Liu 1,*,Chengwei Fei 1,2 andDong Guan 1,3
    Institute of Textiles and Clothing, Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China
    Department of Aeronautics and Astronautics, Fudan University, Shanghai 200433, China
    College of Mechanical Engineering, Yangzhou University, Yangzhou 225127, China
    Sensors 2019, 19(13), 2881;
    Received: 10 May 2019 / Revised: 26 June 2019 / Accepted: 26 June 2019 / Published: 28 June 2019
  4. Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-risk Surgical and Medical Patients
    Evidence-based Synthesis Program
    Investigators: Juliessa M Pavon, MD, John W Williams, Jr, MD, MHSc, Soheir S Adam, MD, Zayd A Razouki, MD, Jennifer R McDuffie, PhD, Paul F Lachiewicz, MD, Andrzej S Kosinski, PhD, Christopher A Beadles, MD, Thomas L Ortel, MD, PhD, and Avishek Nagi, MS.
    Washington (DC): Department of Veterans Affairs (US); 2015 Jun.
  5. Evidence-based compression: prevention of stasis and deep vein thrombosis
    Rhys J Morris 1, John P Woodcock
    Ann Surg. 2004 Feb;239(2):162-71
    Compression levels and indications
  6. High-pressure, rapid-inflation pneumatic compression improves venous hemodynamics in healthy volunteers and patients who are post-thrombotic
    Michael D. Malone, MD, Paul L. Cisek, MD, Anthony J. Comerota, Jr, BA, Burt Holland, PhD,
  7. Intermittent Pneumatic Compression Devices –Physiological Mechanisms of Action REVIEW Article
    A. H. Chen∗, S. G. Frangos, S. Kilaru and B. E. Sumpio
    Yale University School of Medicine, Section of Vascular Surgery, 333 Cedar Street, FMB 137,New Haven, CT 06520, U.S.A. Eur J Vasc Endovasc Surg 21, 383–392 (2001)
  8. Intermittent pneumatic compression pump settings for the optimum reduction of oedema
    Author SueGrieveson
    Senior I Physiotherapist and Moving and Handling Advisor, Moving and Handling Department, Salford NHS Primary Care Trust, Salford
    Received 4 November 2002, Revised 5 December 2002, Accepted 27 May 2003, Available online 24 August 2014
    J.L. Feldman, N.L. Stout, A. Wanchai, B.R. Stewart, J.N. Cormier, J.M. Armer
    NorthShore University HealthSystem (JLF), Evanston, Illinois, Walter Reed Military Medical Center
    (NLS), Bethesda, Maryland, University of Missouri Sinclair School of Nursing
    (AW, BRS, JMA), Columbia, Missouri, and University of Texas MD Anderson Cancer Center (JNC), Houston, Texas Lymphology 45 (2012) 13-25
  10. Intermittierende pneumatische Kompressionstherapie
    Ein Leitfaden für Klinik und Praxis
    Eberhard Rabe, Stefanie Reich-Schupke (Herausgeber)
    WVP. Wirtschafts- und Praxisverlag
    ISBN: 978-3-934371-65-1
    Donald G. MacLellan John P. Fletcher
    First published: 09 May 2007 24
    D. G. MacLellan MD, MBA, FRACS; J. P. Fletcher MD, MS, FRACS.
  12. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous Thrombosis
    T J Tarnay, P R Rohr, A G Davidson, M M Stevenson, E F Byars, G R Hopkins
    Surgery. 1980 Oct;88(4):489-96.
  13. Pneumatic Compression Pump Therapy: An Evidence-based Approach to the Treatment of Chronic Vascular Disorders
    Today’s wound clinic September 25, 2009
    Volume 2 Issue 1 – Winter 2008 Teresa Conner-Kerr, PT, PhD, CWS, CLT
  14. Preventing Venous Thromboembolism with intermittend Pneumatic Compression
    Clinical evidence summary by arjo medical, Malmö SE
  15. S1 guidelines on intermittend pneumatic compression (IPC)
    English version in Hautarzt 2018 Aug:69(8)662-673
  16. S1 Leitlinie Intermittierende Kompression (IPK,AIK)
    AWMF Registernummer 037/007
    In der AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V.) sind 179 wissenschaftliche Fachgesellschaften (+3 assoziierte) aus allen Bereichen der Medizin zusammengeschlossen
  17. S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE)
    2. komplett überarbeitete Auflage, Seiten 32-34;
    AWMF Leitlinien-Register Nr. 003/001
    Stand: 15.10.2015
  18. The influence of inflation rate on the hematologic and hemodynamic effects of intermittent pneumatic calf compression for deep vein thrombosis prophylaxis
    Rhys J.MorrisPhDaJohn C.GiddingsPhD, FRCPathbHeather M.RalisFIBMSbGwyneth M.JenningsBScbDelyth A.DaviesAIBMSbJohn P.WoodcockPhD, DScacFrank D.J.DunstanPhDd
    Journal of Vascular Surgery Volume 44, Issue 5, November 2006, Pages 1039-1045

ICU tech GmbH
Bahnhofstrasse 2
CH-3534 Signau

+41 (0) 34 497 28 20

© 2022 Quisanus AG